Male dosing
Not establishedNo validated clinical regimen
RESEARCH USE ONLY · CANADA 19+ · UNITED STATES 21+
Under MGMT Research store policy, visitors in Canada must be at least 19 years old and visitors in the United States must be at least 21 years old. By entering, you confirm that you meet the minimum age for your country.
Every compound shown is presented strictly for controlled laboratory and analytical research—not for human or veterinary use.
Research and analytical use only
Not for human or veterinary use
Responsible handling required
You must be 19+ in Canada or 21+ in the United States to enter MGMT Research.
MGMT RESEARCH

GHK-Cu · Copper tripeptide complex
CU-TACH is our name for GHK-Cu, a copper-binding peptide studied for its role in skin rejuvenation, age-related skin changes, and tissue repair. GHK occurs naturally in the human body and forms a complex with copper ions. Research on GHK-Cu explores collagen production, tissue remodeling, and cellular responses, making it a compound of interest in skincare and regenerative research.
COA pending. Independent testing will be performed by SideChain Analytics in Mississauga, Ontario.
Every compound vial includes one free 3 mL Bacteriostatic Water and one compound / BAC pair holder. Any strength. No minimum purchase. Bundles count their included BAC Water toward this offer.
Tax-inclusive CAD pricing. E-transfer accepted · Credit cards coming soon.
Includes FREE 3 mL BAC Water + a compound / BAC pair holder with every vial.
Mix Easy · Open the calculator ↗No validated clinical regimen
No validated clinical regimen
Follow the validated laboratory method
Cosmetic and preclinical literature
No validated value for this product
No validated PCT protocol
Human safety data for injectable GHK-Cu are limited. Laboratory, cosmetic, and preclinical findings do not establish an injectable dosing regimen for CU-TACH. FDA research context ↗
CU-TACH is our name for GHK-Cu, the copper complex of glycyl-L-histidyl-L-lysine. This copper-binding tripeptide is investigated in skin biology, collagen synthesis, extracellular matrix remodeling, and tissue-repair models.
Your selected vial contains 50 mg of labeled lyophilized compound. This is the total vial amount, not a dose or a prepared solution concentration.
GHK occurs naturally in human biological fluids and forms a complex with copper ions. Research findings depend on the model, preparation, and experimental conditions.
GHK-Cu research explores cellular and matrix-related responses. These are areas of investigation, not promised outcomes from CU-TACH.
Follow batch-specific supplier instructions and your laboratory’s validated storage and reconstitution procedures. A prepared solution’s shelf life has not been established for this product.
Orders received before 12 PM EST ship the same business day.
COA pending. Purity and net-content results will be published when the batch-specific report is available.
Select your compound, vial amount, diluent volume, and sample amount. Our calculator converts your inputs into a concentration, volume, and U-100 syringe marking.
Enter an example amount to calculate its volume.
0.2 mL of solution per sample
2 mg ÷ 10 mg/mL = 0.2 mL
Concentration = vial amount ÷ solution volume. Sample volume = sample amount ÷ concentration. U-100 scale units = volume in mL × 100; these are volume markings, not units of compound potency.
This example assumes the final solution volume equals the diluent volume entered, and that the compound dissolves completely. It does not establish solubility, compatibility, stability, or an administration dose.
Decimal measurements are mathematical results and may fall between markings. Full samples are rounded down; they do not account for handling losses.
The calculator checks concentration mathematics. It does not select a treatment dose or establish compatibility, sterility, or stability. SEMARO is temporarily unavailable and is omitted from this selector. BAC Water is the diluent, not a peptide.
Human safety information for injectable GHK-Cu is limited. The FDA identifies potential immunogenicity concerns related to aggregation and peptide-related impurities in compounded injectable preparations.
Cosmetic or preclinical results do not establish the safety of injecting CU-TACH. A product’s identity and chromatographic purity are separate from sterility, endotoxin status, and clinical safety.
Your selected CU-TACH vial is labeled 50 mg. No validated male or female clinical dosing regimen is established for this research product.
Sample amount, exposure frequency, diluent, and preparation method should come from the specific validated protocol for your research model.
Enter your laboratory’s sample amount and final solution volume into Mix Easy to calculate concentration, sample volume, and U-100 markings. The calculator does not determine a therapeutic dose.
Open Mix Easy ↗